7
Participants
Start Date
August 25, 2020
Primary Completion Date
December 30, 2022
Study Completion Date
July 30, 2023
S48168
A novel oral small molecule which is designed to repair leaky RYR1 channels
National Institutes of Health Clinical Center, Bethesda
Lead Sponsor
Collaborators (1)
National Institute of Neurological Disorders and Stroke (NINDS)
NIH
National Institute of Nursing Research (NINR)
NIH
Celerion
INDUSTRY
Armgo Pharma, Inc.
INDUSTRY